| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/04/1993 | WO1992013950A3 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF β CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 02/04/1993 | CA2113720A1 Induction of cytotoxic t-lymphocyte responses |
| 02/04/1993 | CA2113641A1 Recombinant infectious bovine rhinotracheitis virus |
| 02/04/1993 | CA2113572A1 Improved vaccine |
| 02/04/1993 | CA2113206A1 Modified pf4 compositions and methods of use |
| 02/04/1993 | CA2113202A1 Neural calcium-activated neutral proteinase inhibitors |
| 02/04/1993 | CA2111858A1 Production of antibodies |
| 02/03/1993 | EP0525992A2 Cluster conjugates of drugs with antibodies |
| 02/03/1993 | EP0525910A1 Non-A, non-B peptide |
| 02/03/1993 | EP0525828A2 Recombinant polypeptides and their uses, including assay for aids virus |
| 02/03/1993 | EP0525570A2 Anti-idiotypic antibodies that mimic TNF |
| 02/03/1993 | EP0525502A1 Method for the preparation of virus-inactivated immunoglobuline solutions |
| 02/03/1993 | EP0525119A1 Antibody conjugates for treatment of neoplastic disease |
| 02/03/1993 | CA2075165A1 Non-a, non-b peptide |
| 02/02/1993 | US5183884 Novel proteins (erbB-3 gene) of the erB proto-oncogene family; immunoassay; antitumor and -carcinogenic agents |
| 02/02/1993 | US5183755 Anti-human papillomavirus monoclonal antibody, hybridoma producing the same and process for preparing the same |
| 02/02/1993 | US5183745 Adenyl cyclase derivatives and their biological uses |
| 02/02/1993 | US5183734 Antibodies, diagnostic systems and methods for assaying SV40 HBxAg |
| 02/02/1993 | US5183659 Protection of equines against Streptococcus equi |
| 02/02/1993 | US5183658 A pathogen of hemorrhagic fever with renal syndrome; strain from human body is injected to one-day old mouse, raised to ten days, paralyzing and cutting head apart of rat to take brain, purification, inactivation and addition of adjuvant |
| 02/01/1993 | CA2074662A1 Anti-idiotypic antibodies that mimic tnf |
| 01/28/1993 | DE4124522A1 In-vitro cultivation of human papilloma virus - using kerato-acanthoma replicating the virus as starting cell line with cultivation over at least four weeks |
| 01/27/1993 | EP0524899A1 Recombinant DNA molecules coding for the VB2 T cell receptor, method of preparation, antibodies and medicaments containing them |
| 01/27/1993 | EP0524832A2 Activator gene for macrolide biosynthesis |
| 01/27/1993 | EP0524800A1 Adhesive formulations for binding proteins |
| 01/27/1993 | EP0524672A1 CCV vaccine |
| 01/27/1993 | EP0524584A2 Method for the preparation of high-affinity hapten-specific antibodies and a composition for the detection of haptens |
| 01/27/1993 | EP0524421A1 Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use |
| 01/27/1993 | EP0348442B1 Altered antibody |
| 01/27/1993 | CN1068335A Hepatitis c diagnostics and vaccines |
| 01/27/1993 | CN1068268A Non-stinging vaccine composition |
| 01/27/1993 | CN1068267A Production process of medicine for crop disease of chicken |
| 01/27/1993 | CN1068266A Vaccine and treatment method for human immunodeficiency virus |
| 01/27/1993 | CA2074590A1 Process for the production of high affinity anti-hapten antibodies and composition for the determination of haptens |
| 01/27/1993 | CA2074547A1 Activator gene for macrolide biosynthesis |
| 01/27/1993 | CA2071069A1 Vaccines protective against gram-negative bacteremia and endotoxic shock and related diagnosic assays |
| 01/26/1993 | WO1993001832A1 Vaccine composition |
| 01/26/1993 | US5182257 Anticarcinogenic agents |
| 01/26/1993 | US5182211 Vaccines |
| 01/26/1993 | US5182210 Fowlpox virus promoters |
| 01/26/1993 | US5182109 Vaccine preparation comprising a bacterial toxin adjuvant |
| 01/26/1993 | CA2092302A1 Vaccine composition |
| 01/26/1993 | CA1313151C Vaccine against rinderpest virus using recombinant vaccinia virus |
| 01/21/1993 | WO1993001303A1 Tumor, carbohydrate antigen specific monoclonal antibody and cell line |
| 01/21/1993 | WO1993001302A1 Tumor, carbohydrate antigen specific monoclonal antibody and cell line |
| 01/21/1993 | WO1993001284A1 Recombinant viral vaccine |
| 01/21/1993 | WO1993001281A1 Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| 01/21/1993 | WO1993001279A1 Recombinant hepatitis a virus vaccine |
| 01/21/1993 | WO1993001278A1 Feline lymphoid cell lines capable of producing fiv |
| 01/21/1993 | WO1993001276A1 Continuous cell line and vaccine against avian coccidia |
| 01/21/1993 | WO1993001213A1 Allergenic proteins and peptides from japanese cedar pollen |
| 01/21/1993 | WO1993001211A1 Peptide which abrogates tnf and/or lps toxicity |
| 01/21/1993 | WO1993000927A1 Cancer treatment |
| 01/21/1993 | WO1993000923A1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
| 01/21/1993 | WO1993000919A1 Compositions and methods for inhibiting leukocyte adhesion to cns myelin |
| 01/21/1993 | WO1993000918A1 Short-term anti-cd3 stimulation of lymphocytes to increase their in vivo activity |
| 01/21/1993 | WO1993000917A1 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis |
| 01/21/1993 | WO1992020316A3 Targeted delivery of genes encoding immunogenic proteins |
| 01/21/1993 | CA2113190A1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
| 01/21/1993 | CA2112913A1 Allergenic proteins and peptides from japanese cedar pollen |
| 01/21/1993 | CA2112473A1 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis |
| 01/21/1993 | CA2111564A1 Short-term anti-cd3 stimulation of lymphocytes to increase their in vivo activity |
| 01/20/1993 | EP0523976A2 Manipulation of gene copy number in bordetella |
| 01/20/1993 | EP0523949A1 Production of antibodies |
| 01/20/1993 | EP0523675A1 Inhibitory agent against HIV superinfection |
| 01/20/1993 | EP0523406A1 Use of tri(n-butyl) phosphate at low pH in solutions of biologically active proteins for enhanced virucidal activity |
| 01/20/1993 | EP0523395A2 Seroreactive domains from the HPV 16 E1 and E2 proteins |
| 01/20/1993 | EP0523391A1 Use of HPV-16 E6 and E7-gene derived peptides for the diagnostic purpose |
| 01/20/1993 | EP0523056A1 Neutralizing and/or adcc mediating monoclonal hiv antibody |
| 01/20/1993 | CN1068035A Abrogation of uiral resistance to nucleoside analogues by double-stranded rnas |
| 01/19/1993 | US5180820 Nucleic acid sequence code |
| 01/19/1993 | US5180813 Early envelope glycoprotein of human cytomegalovirus (hmcv) and monoclonal antibodies to the glycoproteins |
| 01/19/1993 | US5180806 Polypeptides and compositions of human papillomavirus latent proteins, diagnostic systems and methods |
| 01/19/1993 | US5180675 Recombinant fowlpox virus |
| 01/19/1993 | US5180660 Methods and materials for HIV detection |
| 01/19/1993 | CA1312837C Pseudorabies vaccine |
| 01/19/1993 | CA1312835C Molecules with antibody combining sites that exhibit catalytic properties |
| 01/14/1993 | DE4122784A1 Drug compsn. for treatment of HIV - contains immunoglobulin and sulphide cpd., which act synergistically on reticuloendothelial system |
| 01/13/1993 | EP0522560A2 Method and composition for the prevention of Lyme disease |
| 01/13/1993 | EP0522535A1 Recombinant marek's disease virus, process for preparing the same and vaccine containing the same |
| 01/13/1993 | EP0522482A2 Coccidiosis vaccines |
| 01/13/1993 | EP0522291A1 Process for purifying hepatitis a virus (HAV), virus thus purified and vaccine compositions containing it |
| 01/13/1993 | EP0522138A1 Influenza virus vaccine composition having a synergistic effect and containing influenza virus core as an additive |
| 01/13/1993 | EP0522136A1 Protective malaria sporozoite surface protein immunogen and gene |
| 01/13/1993 | EP0522134A1 Method of detecting circulating antibody types using dried or lyophilized cells or cell-like material |
| 01/13/1993 | EP0522091A1 Multiple sclerosis t-cell receptor |
| 01/13/1993 | EP0522081A1 Inhibition of disease associated with immunodeficiency virus infection |
| 01/13/1993 | EP0522078A1 Gp75 as a tumor vaccine for melanoma |
| 01/13/1993 | EP0521996A1 Catalytic antibody components |
| 01/13/1993 | CN1067921A Antibiotic compound |
| 01/13/1993 | CA2073588A1 Coccidiosis vaccines |
| 01/12/1993 | US5179019 Therapeutic murine monoclonal antibody |
| 01/12/1993 | US5179018 Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria |
| 01/12/1993 | US5179001 In cystic fibrosis patients |
| 01/12/1993 | US5178882 Viral decoy vaccine |
| 01/12/1993 | US5178862 Canine distemper virus vaccine and method of preparation |
| 01/12/1993 | US5178861 Of a sporozite of the genus splasmodium; malaria vaccine |
| 01/12/1993 | US5178860 Adjuvant complexes and vaccine made therefrom |
| 01/12/1993 | US5178859 Monoclonal antibodies for binding an antigen of Borrelia and epitopes |
| 01/12/1993 | US5178858 Method for prevention of graft versus host disease |